Susquehanna International Group, LLP Harmony Biosciences Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 74,581 shares of HRMY stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,581
Previous 62,545
19.24%
Holding current value
$1.97 Million
Previous $2.08 Million
13.54%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HRMY
# of Institutions
290Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$174 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$154 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$135 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$42.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$41.7 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.56B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...